Broadcast Date: Wednesday, September 27, 2023
from 12:00 pm to 1:00 pm (ET)

Overview:

Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners and intellectual property (IP) lawyers concern the Section 101 jurisprudence related to innovations in the life sciences industry. Moreover, landmark cases like Amgen Inc. v. Sanofi continue to shape the patent landscape, posing profound impacts on invention enablement. These and other developments continue to pose risks that practitioners should be wary of. Canadian jurisprudence deals with similar issues and in some cases, patent practice diverges between the US and Canada.

Listen as experienced patent attorneys Melanie Szweras (Bereskin & Parr LLP) and Kevin E. Noonan, Ph.D. (McDonnell Boehnen Hulbert & Berghoff LLP) provide a comprehensive discussion of the latest trends and challenges in protecting patents in the life science sector. Speakers, among other things, will offer practical tips and strategies for navigating this dynamic regulatory environment.

Key topics include:

  • Life Science Patents: Latest Regulatory Developments in the US and Canada
  • Current Challenges and Regulatory Issues Faced by Patent Owners and IP Lawyers
  • Notable Cases in the US and Canada
  • What Lies Ahead

Credit:

Course Level: 

Intermediate

 

Advance Preparation: 

Print and review course materials

 

Method of Presentation:

On-Demand Webcast

 

Prerequisite: 

General knowledge of patent laws

 

Course Code:

1410641

 

NY Category of CLE Credit:

Areas of Professional Practice

 

Total Credit:

1.0 CLE

Speaker Panel:

Melanie Szweras, Partner
Bereskin & Parr LLP

Melanie Szweras is a partner with Bereskin & Parr LLP and a member of the Life Science’s practice group. She is also co-leader of the Privacy/Regulatory, Advertising, Marketing & Regulatory practice group.

Melanie’s practice focuses on drafting and prosecution of applications relating to biologics, diagnostics, biotechnology, food and pharmaceuticals. Melanie offers strategic advice and expertise to her clients, provides validity and freedom to operate opinions and is involved in related patent litigation and licensing.

Melanie’s privacy work includes advising organizations on compliance with Canadian privacy laws, including PIPEDA, assisting with preparation of privacy policies, terms and conditions, outsourcing agreements and general management of personal information. Her regulatory work includes advising on Health Canada regulated labelling and advertising and on health-related regulations, such as those relating to notices of compliance, certificates of supplementary protection and the Patented Medicines Price Review Board.

Melanie lectures on aspects of Biotechnology and The Application Process at the University of Toronto’s Patent & Trade Secrets Law course and Osgoode Hall’s LLM Patent Law course. Melanie is the Vice-Chair of the Continuing Professional Development Committee for the Intellectual Property Institute of Canada (IPIC) . Melanie also is the Issues Leader of the American Intellectual Property Law Association (AIPLA) Biotechnology Committee.

Melanie received numerous awards throughout her education, including the Medical Research Council Studentship and a University of Toronto Open Scholarship. She was also the Bronze Medalist for her class of 2003 at Osgoode Hall Law School.

Kevin E. Noonan, Ph.D., Partner
McDonnell Boehnen Hulbert & Berghoff LLP

Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and pharmaceutical patent law. Over the past 30 years, he has counseled some of the largest biotechnology and pharmaceutical companies in the world on intellectual property issues.

He helps these companies protect their innovations and advance business goals by developing effective patent portfolio strategies. His work includes helping companies develop global patent filing and prosecution strategies, evaluate litigation risks, and manage patent term extensions. Dr. Noonan also has successfully represented clients in numerous interference proceedings. He has filed amicus briefs in landmark cases involving pharmaceutical and biotechnology patent issues to district courts, the Federal Circuit and the U.S. Supreme Court.

Dr. Noonan is the co-founder of and regular contributor to Patent Docs, a website featuring news and commentary on patent law. He is a co-editor and contributing author of the book, “Claim Construction and the Federal Circuit,” and a contributing author of “Antitrust Issues in Intellectual Property Law.” He also regularly speaks about intellectual property issues at events around the world.

Prior to becoming an attorney, Dr. Noonan was a molecular biologist, earning a doctorate from Princeton University, and a National Cancer Institute postdoctoral fellow.

Agenda:

Melanie SzwerasPartner

Bereskin & Parr LLP

Canadian perspective on the patenting of Life Sciences Inventions. In particular, in relation to the following topics:

  1. Patentable subject matter (genes, higher life organisms, methods of medical treatment, diagnostic methods)
  2. Protection of antibodies (sufficiency of disclosure, enablement, utility/sound prediction, selection patents)
  3. Unity of Invention (double patenting, how it differs from US practice)
  4. Patent Term (Certificates of Supplementary Protection, Patent term extension (new in Canada))
  5. Patented Medicines Price Review Board Update
  6. Miscellaneous prosecution tips (excess claims fees, disclosure grace period calculation, limited number of OAs and RCEs)

Kevin E. Noonan, Ph.D., Partner

McDonnell Boehnen Hulbert & Berghoff LLP

U.S. perspective on the patenting of Life Sciences Inventions. In particular, in relation to the following topics:

  • Patentable subject matter (natural products generally, diagnostic methods, proposed legislation and prospects)
  • Protection of antibodies (enablement and written description issues)
  • Double patenting issues with regard to terminal disclaimers and PTA/PTE; In re Cellect decision
  • Status of CRISPR patenting in US
  • Biologics, biosimilars, and Federal policies on drug pricing
  • Post-grant review issues (Fintiv, Director review, trends, standard or review/judgment, more proposed legislation)

Date & Time:

Wednesday, September 27, 2023

12:00 pm to 1:00 pm (ET)

Who Should Attend:

  • Patent Attorneys and Consultants
  • Intellectual Property Lawyers and Consultants
  • Biotechnology/Pharmaceutical Lawyers
  • Patent Managers
  • Intellectual Property Managers
  • Patent Agents
  • General/In-House Counsel
ImageNameSummaryPriceBuy
Antitrust 'No-Poach' Agreement Enforcement: Key Focus Areas in 2024

CLE: 1.5 Credits | Broadcast Date: Check back for updates or Click Here and get notified of the new date | Price Includes CLE & Recording

$69.00
Asbestos Litigation: Demystifying Trends, Developments, and Defense Strategies

CLE: 1.0 Credit | Broadcast Date: Thursday, May 26, 2022, from 12:00 PM to 1:00 PM ET | Price Includes CLE & Recording

$69.00
Asbestos Litigation: What's Changing in 2024 and Beyond

CLE: 1.5 Credit | Broadcast Date: Tuesday, July 9, 2024, from 12:00 pm to 1:30 pm (ET) | Price Includes CLE & Recording

$69.00
Cartel Investigations: A Blueprint for Defense

CLE: 1.5 Credits | Broadcast Date: Tuesday, May 21, 2024, from 12:00 PM to 1:30 PM ET | Price Includes CLE & Recording

$69.00
CLE Processing

Online Payment for CLE Processing

$35.00$150.00
Cybersecurity Management: Best Practices in a Remote Environment

CLE: 1.5 Credits | CPE: 1.5 Credits (Not eligible for QAS (On-demand) CPE credit) | Broadcast Date: Thursday, April 22, 2021 from 12:00 pm to 1:30 pm (ET) | Price Includes CLE & Recording

$69.00
Demystifying Economic Sanctions: Strategies for Success in a Global Economy

CLE: 1.0 Credit | Broadcast Date: Tuesday, May 14, 2024, from 12:00 pm to 1:00 pm ET | Price Includes CLE & Recording

$69.00
Executive Compensation: Hot Topics and Emerging Trends

CLE: 1.0 Credits| Broadcast Date: Monday, November 18, 2024, from 12:00 PM to 1:00 PM (ET) | Price Includes Recording

$69.00
Hatch-Waxman Case-Law Developments and New Jersey Practice Insights

CLE: 1.0 Credit | Broadcast Date: Wednesday, October 23, 2024, from 12:00 PM to 1:00 PM (ET) | Price Includes CLE & Recording

$69.00
Mastering the Art of Demonstrating and Recouping Lost Profit Damages: A Hands-On Guide

CLE: 1.0 Credit | Broadcast Date: Tuesday, November 12, 2024. from 12:00 PM to 1:00 PM (ET) | Price Includes CLE & Recording

$69.00
Maximizing Your Innovation ROI: R&D Tax Credits in 2024 and Beyond

CLE: 1.0 CLE | 1.0 CPE (Not eligible for QAS (On-demand) CPE credit) | Broadcast Date: Thursday, March 28, 2024, from 12:00 PM to 1:00 PM ET | Price Includes CLE & Recording

$69.00
Navigating Challenges in Patent Damages Analysis: Key Considerations for Litigants and Counsel

CLE: 1.0 Credit | CPE: 1.0 Credit (Not eligible for QAS (On-demand) CPE credit) | Broadcast Date: Wednesday, December 13, 2023, from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00
Navigating Double Patenting in the USPTO Era of Rulemaking

CLE: 1.5 Credits | Broadcast Date: Tuesday, February 25, 2025, from 12:00 PM to 1:30 (ET) | Price Includes CLE Credits & Recording

$69.00
Navigating the Evolving Patent Damages Landscape: Key Insights and Best Practices

CLE: 1.0 Credits | Broadcast Date: Thursday, June 27, 2024, from 12:00 PM to 1:00 PM (ET) | Price Includes CLE & Recording

$69.00
Navigating the FTC's Final Rule on Noncompete Agreements: Critical Insights for Employers

CLE: 1.5 Credits| Broadcast Date: Wednesday, September 4, 2024, from 12:00 PM to 1:30 PM (ET) | Price Includes CLE Credits & Recording

$69.00
New York Online CLE Bundle 2023

This bundle allows you to complete 24 New York CLE credits. These courses are all on-demand and can be completed at your convenience.

 

 

 

$199.00
Preventing Ransomware Attacks: A Practical Guide to Enhancing IT Security and Resiliency

CLE: 1.5 Credits  | Broadcast Date: Monday, September 13, 2021 from 12:00 pm to 1:30 pm (ET) | Price Includes CLE & Recording

$69.00
Speaker Preferred Package (Online Payment)

Speaker Preferred Package (for Credit Payment processing)

$599.00$799.00
Sponsorship

Online Payment for Sponsorship

$5,500.00$15,000.00
Supercharging Privilege Review With AI, Analytics, and Automation

CLE: 1.0 Credit| Broadcast Date: Friday, February 25, 2022 from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00
The Future of Insurance Claims: Using Generative AI to Combat Bad Faith

CLE: 1.5 Credits| Broadcast Date: Wednesday, December 18, 2024, from 12:00 PM to 1:30 PM (ET) | Price Includes CLE Credits & Recording

$69.00
The Hows and Whys of Child Abuse Reporting: A Comprehensive Ethical Guide for Lawyers

CLE: 2.0 Credits | Broadcast Date: Wednesday, June 29, 2022 from 12:00 pm to 2:00 pm (ET) | Price Includes CLE & Recording

$69.00
Trade Secrets, and What You Need to Know to Protect Them

CPE: 2.0 Credits | Broadcast Date: Thursday, December 5, 2024, from 12:00 PM to 2:00 PM (ET) | Price Includes CLE Credits & Recording

$69.00
Understanding R&D Tax Credits and Amortization: Navigating Changes and Maximizing Benefits

CLE: 1.5 Credits | CPE: 1.5 Credits (Not eligible for QAS (On-demand) CPE credit) | Broadcast Date: Wednesday, August 30, 2023 from 12:00 PM to 1:30 PM (ET) | Price Includes CLE & Recording

$69.00
Winning Patent Litigation: Essential Strategies and Tactics

CLE: 1.0 Credit | Broadcast Date: Wednesday, April 25, 2024 from 12:00 PM to 1:00 PM ET | Price Includes CLE & Recording

$69.00
Practical Trademark Perspectives from U.S. and Canadian Counsel

CLE: 1.5 Credits | Broadcast Date: Tuesday, September 28, 2021 from 3:00 to 4:30 PM ET | Price Includes CLE & Recording

$69.00
Effectively Manage KYC Compliance: Keep Up with the Times by Getting Back to Basics

CLE: 1.0 Credit | Broadcast Date: Wednesday, August 11, 2021 from 3:00 PM to 4:00 PM ET | Price Includes CLE & Recording

$69.00
OFAC Regulations and the Economic Sanctions Compliance Programs: Best Practices

CLE: 1.0 | Broadcast Date: Thursday, September 29, 2022 from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00
'Zombie' LIBOR for USD Contracts: Navigating the Critical Issues

CLE: 1.0 Credit | CPE: 1.0 Credit (Not eligible for QAS (On-demand) CPE credits) | Broadcast Date: Wednesday, May 12, 2021 from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00
Calculating Lost Profits in Construction Claims: A Practical Guide

CLE: 1.0 Credit | CPE : 1.0 Credit (Not eligible for QAS (On-demand) CPE credits) | Broadcast Date: Monday, January 25, 2021 from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00
False Claims Act and COVID-19 Implications: Key Considerations and Best Practices

CLE: 1.0 Credit | CPE: 1.0 Credit (Not eligible for QAS (On-demand) CPE credits) | Broadcast Date: Wednesday, February 24, 2021 from 12:00 pm to 1:00 pm (ET) | Price Includes CLE & Recording

$69.00

SPEAKERS

Melanie SzwerasPartner
Bereskin & Parr LLP
Kevin E. Noonan, Ph.D.Partner
McDonnell Boehnen Hulbert & Berghoff LLP

SUBSCRIPTION PACKAGES

ALL-ACCESS PASS

View Details

CLE LAW MONTHLY

View Details

CPE FINANCE MONTHLY

View Details

Join Over 160,000 Professionals Empowering Their Careers

Learn anywhere from over 3000+ live and recorded CLE, CPE & Technology Webcasts.